Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Distinct binding mode of I-125-AngII to AT(1) receptor without the Cys(18)-Cys(274) disulfide bridge

Full text
Martin, Renan P. [1] ; Rodrigues, Eliete S. [1] ; Pacheco, Nelson A. S. [1] ; Correa, Silvana A. A. [1] ; Oliveira, Suzana M. [1] ; Oliveira, Laerte [1] ; Nakaie, Clovis R. [1] ; Shimuta, Suma I. [1]
Total Authors: 8
[1] Univ Fed Sao Paulo, Dept Biophys, BR-04023062 Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Regulatory Peptides; v. 158, n. 1-3, p. 14-18, NOV 27 2009.
Web of Science Citations: 2

Previous studies on angiotensin II (AngII) AT(1) receptor function have revealed that the N-terminal residues of AngII may modulate receptor activation by binding at the receptor extracellular site. A remarkable feature of this site is an insertion of 8 amino acids in the middle of the EC-3 loop including the Cys(274) residue that supposedly makes a disulfide bond with N-terminal Cys(18). As demonstrated by assays with Del(267-275)AT(1), the role of the Cys(18)-Cys(274) disulfide bridge is to keep a conformation of the inserted residues that allows a normal binding of the AngII N-terminal residues. C18S AT(1) receptor mutant, supposedly having a dissociated disulfide bridge, but an intact residue insertion, is constitutively activated and can less efficiently bind AngII. Similar results were observed when the S-S disulfide bond was disrupted in (C18S,C274S) AT(1) receptor. The importance of the free N-terminal amino group of Asp(1) and of the Arg(2) guanidino group for the binding of AngII to C18S mutant with EC-3 loop insertion was investigated by means of assays using AngII peptide analogues bearing a single mutation of Asp(1) for Sar(1) or Arg(2) for Lys(2), as ligands. This study showed that like AngII, {[}Sar(1)]-AngII can bind the C185 mutant receptor with low affinity whereas {[}Lys(2)]-AngII binding is still more reduced. Interestingly, when (125)I-AngII instead of (3)H-AngII was used, no significant binding of this mutant was observed although wild type AT, receptor was shown to bind all AngII analogues. (C) 2009 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 07/01910-0 - Identification of different binding modes of Angiotensin II N-terminal domain with wild-type and mutant AT1 receptors
Grantee:Renan Paulo Martin
Support Opportunities: Scholarships in Brazil - Master